title: Inhibition of alpha-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognizing dihydrolipoamide succinyltransferase in primary biliary cirrhosis.
abstract: Sera from patients with primary biliary cirrhosis contain autoantibodies that recognize mitochondrial proteins. Five of the target autoantigens have now been identified as enzymes of three related multienzyme complexes: the pyruvate dehydrogenase complex, the branched chain alpha-ketoacid dehydrogenase complex and the alpha-ketoglutarate dehydrogenase complex. Each complex consists of component enzymes designated E1, E2 and E3. In this report, we confirm that primary biliary cirrhosis sera react with dihydrolipoamide succinyltransferase, the E2 component of alpha-ketoglutarate dehydrogenase complex. Seventy-three of 188 (39%) primary biliary cirrhosis sera reacted with alpha-ketoglutarate dehydrogenase complex-E2 when immunoblotted against purified alpha-ketoglutarate dehydrogenase complex; one of these sera also reacted with the E1 component. In addition, primary biliary cirrhosis sera possessing alpha-ketoglutarate dehydrogenase complex-E2 reactivity specifically inhibited enzyme function of alpha-ketoglutarate dehydrogenase complex. Enzyme activity was not affected by primary biliary cirrhosis sera that contained autoantibodies to pyruvate dehydrogenase complex-E2 and/or branched chain alpha-ketoacid dehydrogenase complex-E2, which lacked alpha-ketoglutarate dehydrogenase complex-E2 reactivity. Furthermore, affinity-purified primary biliary cirrhosis sera against alpha-ketoglutarate dehydrogenase complex-E2 inhibited only alpha-ketoglutarate dehydrogenase complex activity but did not alter enzyme activity of either pyruvate dehydrogenase complex or branched chain alpha-ketoacid dehydrogenase complex. Finally, alpha-ketoglutarate dehydrogenase complex-E2 specific affinity-purified antisera did not react on immunoblot with any component enzymes of pyruvate dehydrogenase complex or branched chain alpha-ketoacid dehydrogenase complex.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Division of Clinical Immunology, University of California, Davis 95616.
authors.forename: D R
authors.initials: DR
authors.lastname: Fregeau
authors.forename: T
authors.initials: T
authors.lastname: Prindiville
authors.forename: R L
authors.initials: RL
authors.lastname: Coppel
authors.forename: M
authors.initials: M
authors.lastname: Kaplan
authors.forename: E R
authors.initials: ER
authors.lastname: Dickson
authors.forename: M E
authors.initials: ME
authors.lastname: Gershwin
mesh_terms: D000042:Absorption; D000217:Acyltransferases / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology* / Q000502:physiology; D006801:Humans; D015151:Immunoblotting; D007132:Immunoglobulin Isotypes / Q000145:classification / Q000276:immunology; D007655:Ketoglutarate Dehydrogenase Complex / Q000037:antagonists & inhibitors* / Q000276:immunology; D007658:Ketone Oxidoreductases / Q000037:antagonists & inhibitors*; D008105:Liver Cirrhosis, Biliary / Q000201:enzymology* / Q000276:immunology; D008928:Mitochondria / Q000276:immunology
chemical_list: D001323:Autoantibodies; D007132:Immunoglobulin Isotypes; D007658:Ketone Oxidoreductases; D007655:Ketoglutarate Dehydrogenase Complex; D000217:Acyltransferases; C021515:dihydrolipoamide succinyltransferase